— Know what they know.
Not Investment Advice

DRTSW NASDAQ

Alpha Tau Medical Ltd.
1W: +0.3% 1M: +10.1% 3M: +88.0% YTD: +962.2% 1Y: +1341.7% 3Y: +1601.3%
$3.93
-0.07 (-1.75%)
 
Weekly Expected Move ±12.1%
$3 $3 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 48 · $1.5B mcap · 62M float · 0.120% daily turnover · Short 64% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$1.5B
52W Range0.3251-4.07
Volume17,238
Avg Volume74,199
Beta1.19
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOUzi Sofer
Employees112
SectorHealthcare
IndustryBiotechnology
IPO Date2026-03-06
Kiryat HaMada St. 5
Jerusalem, JM 9777605
IL
972 3 577 4115
About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Recent Insider Trades

NameTypeSharesPriceDate
Avruch Michael 0 2026-03-18
Avruch Michael 0 2026-03-18
Avruch Michael 0 2026-03-18
Avruch Michael 15,527 $6.41 2026-03-18
KIDRON NADAV 0 2026-03-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms